Skip to content
MedsAcross

Medicine

Carnitor 1 g/5 mL injection

Levocarnitine · Intravenous · Leadiant Biosciences
Available on requestPrescription onlyUS FDA

Carnitor 1 g/5 mL injection is a prescription medicine containing Levocarnitine for intravenous use, marketed by Leadiant Biosciences, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store vials at controlled room temperature (25°C).

Key facts

Active ingredient (INN)
Levocarnitine
Brand
Carnitor
Strength
1 g/5 mL
Dosage form
Injection
Route
Intravenous
Packs
5 vials of 5 mL
Marketing authorisation holder
Leadiant Biosciences
Manufacturer
Leadiant Biosciences
Origin register
US FDA, United States
Storage
Store vials at controlled room temperature (25°C).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
16 December 1992
Identifiers
RxCUI 206345, 1791371DailyMed set ID cf801cc4-775e-433d-9d32-e5d9a98981d3NDC 54482-147Application NDA020182

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
5 vial in 1 carton / 5 mL in 1 vial54482-147-01Leadiant Biosciences16 December 1992

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 27 December 1985Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Levocarnitine 1 g/5 mL injection.

Compare 1

Other strengths and forms of Levocarnitine

Clinical summary

Levocarnitine is a carnitine analog indicated in the treatment of primary systemic carnitine deficiency, among other approved uses. It is available as injection, oral solution and tablets for intravenous use. MedsAcross supplies Levocarnitine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Levocarnitine

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Carnitor 1 g/5 mL injection for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.